QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Supplemental Research Data Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by McMullan, R. Articles by Nurrish, S. J. Search for Related Content PubMed PubMed Citation Articles by McMullan, R. Articles by Nurrish, S. J. Social Bookmarking                   What's this?

RESEARCH PAPER

Rho is a presynaptic activator of neurotransmitter release at pre-existing synapses in C. elegans

MRC Cell Biology Unit, MRC Laboratory for Molecular Cell Biology and Department of Pharmacology, University College, London WC1E 6BT, United Kingdom

Rho GTPases have important roles in neuronal development, but their function in adult neurons is less well understood. We demonstrate that presynaptic changes in Rho activity at Caenorhabditis elegans neuromuscular junctions can radically change animal behavior via modulation of two separate pathways. In one, presynaptic Rho increases acetylcholine (ACh) release by stimulating the accumulation of diacylglycerol (DAG) and the DAG-binding protein UNC-13 at sites of neurotransmitter release; this pathway requires binding of Rho to the DAG kinase DGK-1. A second DGK-1-independent mechanism is revealed by the ability of a Rho inhibitor (C3 transferase) to decrease levels of release even in the absence of DGK-1; this pathway is independent of UNC-13 accumulation at release sites. We do not detect any Rho-induced changes in neuronal morphology or synapse number; thus, Rho facilitates synaptic transmission by a novel mechanism. Surprisingly, many commonly available human RhoA constructs contain an uncharacterized mutation that severely reduces binding of RhoA to DAG kinase. Thus, a role for RhoA in controlling DAG levels is likely to have been underestimated.

[Keywords: RhoA; animal behavior; synaptic vesicle release; DAG kinase; Munc13; C. elegans]

Received July 18, 2005; revised version accepted October 31, 2005.

Article and publication are at http://www.genesdev.org/cgi/doi/10.1101/gad.359706.

¹ Corresponding author.

E-MAIL s.nurrish{at}ucl.ac.uk; FAX 44-20-76797805.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. M. Tokuoka, A. Saiardi, and S. J. Nurrish The Mood Stabilizer Valproate Inhibits both Inositol- and Diacylglycerol-signaling Pathways in Caenorhabditis elegans Mol. Biol. Cell, May 1, 2008; 19(5): 2241 - 2250. [Abstract] [Full Text] [PDF]

				E. Marza, T. Long, A. Saiardi, M. Sumakovic, S. Eimer, D. H. Hall, and G. M. Lesa Polyunsaturated Fatty Acids Influence Synaptojanin Localization to Regulate Synaptic Vesicle Recycling Mol. Biol. Cell, March 1, 2008; 19(3): 833 - 842. [Abstract] [Full Text] [PDF]

				R. McMullan and S. J. Nurrish Rho deep in thought Genes & Dev., November 1, 2007; 21(21): 2677 - 2682. [Full Text] [PDF]

				S. L. Williams, S. Lutz, N. K. Charlie, C. Vettel, M. Ailion, C. Coco, J. J.G. Tesmer, E. M. Jorgensen, T. Wieland, and K. G. Miller Trio's Rho-specific GEF domain is the missing G{alpha}q effector in C. elegans Genes & Dev., November 1, 2007; 21(21): 2731 - 2746. [Abstract] [Full Text] [PDF]

				M. Diogon, F. Wissler, S. Quintin, Y. Nagamatsu, S. Sookhareea, F. Landmann, H. Hutter, N. Vitale, and M. Labouesse The RhoGAP RGA-2 and LET-502/ROCK achieve a balance of actomyosin-dependent forces in C. elegans epidermis to control morphogenesis Development, July 1, 2007; 134(13): 2469 - 2479. [Abstract] [Full Text] [PDF]